Medtronic launches Valiant Evo TAA device trial
Medtronic (NYSE:MDT) said today it enrolled the 1st patient in a trial of its Valiant Evo thoracic stent graft system designed for the minimally invasive repair of descending thoracic aortic aneurysms....
View ArticleMassDevice.com +5 | The top 5 medtech stories for June 8, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticlePalo Alto Advanced Life Sciences Fund raises $40m
Palo Alto Investors have raised $40 million for its newly launched Advanced Life Sciences Fund, according to a new SEC filing. The fund looks to invest in healthcare companies who have “outgrown the...
View ArticleAirXpanders raises $15m, taps medtech vet Murcray for CFO-COO role
AirXpanders (ASX:AXP) said today that it raised $14.9 million (A$20 million) for its AeroForm tissue expander and tapped medical device veteran Scott Murcray to be its CFO/COO. Palo Alto, Calif.-based...
View ArticleSensus Healthcare closes $11m IPO
Sensus Healthcare (NSDQ:SRTSU) said today it closed its initial public offering, raising $11 million through the sale of 2.3 million units at $5.50 each. The offering included a fully-exercised...
View ArticlePHG CEO van Houten: Tech-savvy patients drive the agenda
(Reuters) – Demand from technology-savvy patients seeking control over their medical data will overcome privacy concerns about the “connected” products and services Royal Philips (NYSE:PHG) is now...
View ArticleCantel Medical jumps on Street-beating Q3
Cantel Medical (NYSE:CMN) today released its 3rd quarter earnings for its fiscal year 2016, beating the Street across the board and seeing shares lift. The Little Falls, N.J.-based company reported...
View ArticleInspireMD lifts COO Barry to the corner office | Personnel Moves June 8, 2016
InspireMD lifts COO Barry to the corner office InspireMD (OTC:NSPR) said yesterday it promoted COO Dr. James Barry to the office of CEO and president, effectively immediately. Former CEO Alan Milinazzo...
View ArticleBoston Scientific: Headcount ‘relatively unchanged’ in restructuring, but...
Boston Scientific (NYSE:BSX) said yesterday that the next stage in the turnaround engineered by chairman & CEO Mike Mahoney will involve an unspecified number of layoffs, although its overall...
View ArticleNxStage Medical jumps on Baxter’s exit from the home hemodialysis market
Share prices for NxStage Medical (NSDQ:NXTM) jumped this week after Baxter (NYSE:BAX) CEO Joe Almeida said the company is pulling the plug on its Vivia home hemodialysis device. Almeida, speaking at...
View ArticleStudy: Insurance restrictions on lumbar fusions push procedure volumes down
An insurance policy limit on lumbar fusion procedures helped slash costs and medically unnecessary surgeries in North Carolina, and the approach could work nationally, according to new research...
View ArticleSet your watches: Expected timing of European medical device regulations
By Ronald Boumans, Emergo Group Emergo has received questions about precise timelines regarding the introduction of new European Medical Device Regulations. This indicates there is a strong need within...
View ArticleHouse bill would force docs to report medical device problems to FDA
A bill expected to be introduced today in the U.S. House of Representatives would require doctors to tell the FDA about problems they encounter with medical devices. The “Medical Device Guardian’s...
View ArticleTactile Systems sets terms for $60m IPO
Leg compression device developer Tactile Systems Technology set the terms for its initial public offering today, saying it plans to float 4 million shares at $14 to $16 apiece. At the midpoint, that...
View ArticleFDA reinstates clearance process for Iradimed’s MR-safe MRidium 3860 infusion...
Iradimed (NSDQ:IRMD) said it doesn’t need to perform any more human factors usability testing to get its bid for 510(k) clearance past the FDA for the MRidium 3860+ MRI-safe IV infusion pump. The FDA...
View ArticleStudy: Lower major complication risk with Medtronic’s Micra compared to...
Medtronic (NYSE:MDT) today released new results from a clinical trial of its leadless Micra transcatheter pacing system, touting significantly reduced major complication risks compared to conventional...
View ArticleAscensia Diabetes reups development deal with Medtronic
Asensia Diabetes Care said today it renewed a diabetes management development partnership with Medtronic (NYSE:MDT), through which Ascensia will retain exclusive rights to co-develop and supply Contour...
View ArticleInsulet updates on artificial pancreas, pipeline products
Insulet (NSDQ:PODD) said today it will present new clinical data on its artificial pancreas algorithm, new product pipeline and evidence from studies of its OmniPod system. The news is set to be...
View ArticleNeuroMetrix closes $21.3m funding round
NeuroMetrix (NSDQ:NURO) said yesterday it closed a $21.3 million round of funding through the private placement of preferred stock and warrants to support its Quell wearable pain relief device for...
View ArticleMassDevice.com +5 | The top 5 medtech stories for June 9, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View Article